Literature DB >> 1371553

Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels.

J J Yuan1, D E Coplen, J A Petros, R S Figenshau, T L Ratliff, D S Smith, W J Catalona.   

Abstract

Measurement of serum prostate specific antigen (PSA) is commonly used to evaluate the prostate gland in a variety of clinical settings. We examined the effects of prostatic manipulations, including digital rectal examination, prostate massage, transrectal ultrasonography and transrectal needle biopsy, on serum PSA levels in 199 men. We detected no clinically significant difference between serum PSA levels obtained immediately before and at 5 or 90 minutes after rectal examination in 43 men. We observed falsely increased PSA levels (to greater than 4 ng./ml., Tandem-R) in 1 of 17 men (6%) following prostatic massage and in 3 of 27 men (11%) following ultrasonography. Transrectal needle biopsy caused an immediate increase in serum PSA in 92 of 100 men. In 29 of these 92 men (32%) when followed weekly serum PSA levels did not return to baseline as expected according to the published serum PSA half-life of 2 to 3 days. Biopsies taking 3 or fewer cores (7 patients) resulted in a smaller increase in serum PSA (mean 1.63 +/- 1.12 times the baseline level versus 6.24 +/- 1.10 times baseline, p less than 0.03) and a proportionally shorter duration of PSA elevation (mean 1.43 +/- 0.48 weeks versus 2.13 +/- 0.14 weeks, p = 0.20) than those taking 4 or more cores (93 patients). Prostate size and the presence of cancer had no influence on the duration of PSA elevation following biopsy. We conclude that digital rectal examination, prostatic massage and ultrasonography have minimal effects on serum PSA levels in most patients. However, prostatic needle biopsy usually causes marked elevations of serum PSA levels with a persistent PSA leak into the blood stream lasting longer than expected from the serum half-life of PSA in approximately 25% of the patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371553     DOI: 10.1016/s0022-5347(17)37392-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

Review 1.  Addressing the need for repeat prostate biopsy: new technology and approaches.

Authors:  Michael L Blute; E Jason Abel; Tracy M Downs; Frederick Kelcz; David F Jarrard
Journal:  Nat Rev Urol       Date:  2015-07-14       Impact factor: 14.432

2.  Age-specific PSA reference ranges in a group of non-urologic patients.

Authors:  A C Atalay; M I Karaman; S Güney; A Dalkiliç; A Y Müslümanoğlu; E Ergenekon
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

3.  Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma.

Authors:  M Cetinkaya; S Günçe; E Ulusoy; F Aksoy; O Yildiz; O Adsan; C Ozden
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

4.  The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer.

Authors:  Michael A Maccini; Nicholas J Westfall; Adrie Van Bokhoven; Marshall Scott Lucia; Wendy Poage; Paul D Maroni; Shandra S Wilson; Leonard Michael Glodé; Paul Arangua; Jay Newmark; Mitchell Steiner; Priya N Werahera; Elward David Crawford
Journal:  Prostate       Date:  2018-02-19       Impact factor: 4.104

5.  Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.

Authors:  Stephanie T Page; Daniel W Lin; Elahe A Mostaghel; Brett T Marck; Jonathan L Wright; Jennifer Wu; John K Amory; Peter S Nelson; Alvin M Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

6.  Changes of serum prostate-specific antigen following high energy thick loop prostatectomy.

Authors:  R F Talic; A M El-Tiraifi; S Altaf; T B Hargreave
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

Review 7.  Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.

Authors:  B G Muller; W van den Bos; M Brausi; J J Fütterer; S Ghai; P A Pinto; I V Popeneciu; T M de Reijke; C Robertson; J J M C H de la Rosette; S Scionti; B Turkbey; H Wijkstra; O Ukimura; T J Polascik
Journal:  World J Urol       Date:  2015-01-06       Impact factor: 4.226

8.  Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer.

Authors:  M Koch; P Kienle; P Sauer; F Willeke; K Buhl; A Benner; T Lehnert; C Herfarth; M von Knebel Doeberitz; J Weitz
Journal:  Surg Endosc       Date:  2004-01-23       Impact factor: 4.584

9.  Does Rigid Cystoscopy Affect the Total Serum Prostate-Specific Antigen Levels?

Authors:  Iqbal Singh; Ravi Prasad; Vivek Agarwal; R L Tripathi
Journal:  Indian J Surg       Date:  2013-02-15       Impact factor: 0.656

10.  A Review on the Clinical Utility of PSA in Cancer Prostate.

Authors:  Mohan Adhyam; Anish Kumar Gupta
Journal:  Indian J Surg Oncol       Date:  2012-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.